Tuberc Respir Dis.  2015 Apr;78(2):64-71. 10.4046/trd.2015.78.2.64.

Diagnosis of Pulmonary Tuberculosis: Recent Advances and Diagnostic Algorithms

• Ryu YJ

• KMID: 2320596
• DOI: http://doi.org/10.4046/trd.2015.78.2.64

Abstract

Pulmonary tuberculosis (TB) persists as a great public health problem in Korea. Increases in the overall age of the population and the rise of drug-resistant TB have reinforced the need for rapid diagnostic improvements and new modalities to detect TB and drug-resistant TB, as well as to improve TB control. Standard guidelines and recent advances for diagnosing pulmonary TB are summarized in this article. An early and accurate diagnosis of pulmonary TB should be established using chest X-ray, sputum microscopy, culture in both liquid and solid media, and nucleic acid amplification. Chest computed tomography, histopathological examination of biopsy samples, and new molecular diagnostic tests can be used for earlier and improved diagnoses, especially in patients with smear-negative pulmonary TB or clinically-diagnosed TB and drug-resistant TB.

Keyword

Lung; Tuberculosis; Diagnosis

MeSH Terms

Biopsy
Diagnosis*
Humans
Korea
Lung
Microscopy
Pathology, Molecular
Public Health
Sputum
Thorax
Tuberculosis
Tuberculosis, Pulmonary*

Reference

1. World Health Organization. Global tuberculosis report 2014 [Internet]. Geneva: World Health Organization;2014. cited 2015 Mar 1. Available from: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf?ua=1.

2. Park YK, Park YS, Na KI, Cho EH, Shin SS, Kim HJ. Increased tuberculosis burden due to demographic transition in Korea from 2001 to 2010. Tuberc Respir Dis. 2013; 74:104–110.

3. World Health Organization. Early detection of tuberculosis: an overview of approaches, guidelines and tools [Internet]. Geneva: World Health Organization;2011. cited 2015 Mar 1. Available from: http://www.who.int/iris/handle/10665/70824#sthash.TN5snAtB.dpuf.

4. Woodring JH, Vandiviere HM, Fried AM, Dillon ML, Williams TD, Melvin IG. Update: the radiographic features of pulmonary tuberculosis. AJR Am J Roentgenol. 1986; 146:497–506.

5. Krysl J, Korzeniewska-Kosela M, Muller NL, FitzGerald JM. Radiologic features of pulmonary tuberculosis: an assessment of 188 cases. Can Assoc Radiol J. 1994; 45:101–107.

6. Grossman RF, Hsueh PR, Gillespie SH, Blasi F. Community-acquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones. Int J Infect Dis. 2014; 18:14–21.

7. Wang M, Fitzgerald JM, Richardson K, Marra CA, Cook VJ, Hajek J, et al. Is the delay in diagnosis of pulmonary tuberculosis related to exposure to fluoroquinolones or any antibiotic? Int J Tuberc Lung Dis. 2011; 15:1062–1068.

8. World Health Organization. Definitions and reporting framework for tuberculosis: 2013 revision (updated December 2014) [Internet]. Geneva: World Health Organization;2013. cited 2015 Mar 1. Available from: http://apps.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf?ua=1.

9. National Institute for Health and Clinical Excellence. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: National Institute for Health and Clinical Excellence;2011.

10. Wilson ML. Recent advances in the laboratory detection of Mycobacterium tuberculosis complex and drug resistance. Clin Infect Dis. 2011; 52:1350–1355.

11. Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 2nd ed. Seoul and Cheongwon: Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention;2014.

12. International standards for tuberculosis care, 3rd ed [Internet]. The Hague: TB Care 1;2014. Available from: http://www.who.int/tb/publications/ISTC_3rdEd.pdf?ua=1.

13. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014; 1:CD009593.

14. Lee KS, Song KS, Lim TH, Kim PN, Kim IY, Lee BH. Adult-onset pulmonary tuberculosis: findings on chest radiographs and CT scans. AJR Am J Roentgenol. 1993; 160:753–758.

15. Geng E, Kreiswirth B, Burzynski J, Schluger NW. Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study. JAMA. 2005; 293:2740–2745.

16. Jones BE, Ryu R, Yang Z, Cave MD, Pogoda JM, Otaya M, et al. Chest radiographic findings in patients with tuberculosis with recent or remote infection. Am J Respir Crit Care Med. 1997; 156(4 Pt 1):1270–1273.

17. Im JG, Itoh H, Shim YS, Lee JH, Ahn J, Han MC, et al. Pulmonary tuberculosis: CT findings: early active disease and sequential change with antituberculous therapy. Radiology. 1993; 186:653–660.

18. World Health Organization. Same-day diagnosis of tuberculosis by microscopy: WHO policy statement [Internet]. Geneva: World Health Organization;2011. cited 2015 Mar 1. Available from: http://www.who.int/iris/handle/10665/44603#sthash.gvkTkPOD.dpuf.

19. Davis JL, Cattamanchi A, Cuevas LE, Hopewell PC, Steingart KR. Diagnostic accuracy of same-day microscopy versus standard microscopy for pulmonary tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2013; 13:147–154.

20. Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, Cunningham J, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006; 6:570–581.

21. World Health Organization. Fluorescent light emitting diode (LED) microscopy for diagnosis of tuberculosis: policy statement [Internet]. Geneva: World Health Organization;2010. cited 2015 Mar 1. Available from: http://www.who.int/tb/laboratory/who_policy_led_microscopy_july10.pdf.

22. Kanchana MV, Cheke D, Natyshak I, Connor B, Warner A, Martin T. Evaluation of the BACTEC MGIT 960 system for the recovery of mycobacteria. Diagn Microbiol Infect Dis. 2000; 37:31–36.

23. Greco S, Girardi E, Navarra A, Saltini C. Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax. 2006; 61:783–790.

24. Ling DI, Flores LL, Riley LW, Pai M. Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS One. 2008; 3:e1536.

25. Centers for Disease Control and Prevention (CDC). Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep. 2009; 58:7–10.

26. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 2000; 161(4 Pt 1):1376–1395.

27. Kwon YS, Koh WJ. Diagnosis of pulmonary tuberculosis and nontuberculous mycobacterial lung disease in Korea. Tuberc Respir Dis. 2014; 77:1–5.

28. World Health Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB): policy statement [Internet]. Geneva: World Health Organization;2008. cited 2015 Mar 1. Available from: http://www.who.int/tb/laboratory/lpa_policy.pdf.

29. Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2009; 13:1320–1330.

30. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis. 1998; 79:3–29.

31. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update [Internet]. Geneva: World Health Organization;2013. cited 2015 Mar 1. Available from: http://www.who.int/iris/handle/10665/112472#sthash.WDSfafG9.dpuf.

32. Weyer K, Mirzayev F, Migliori GB, Van Gemert W, D'Ambrosio L, Zignol M, et al. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J. 2013; 42:252–271.

33. World Health Organization. Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system [Internet]. Geneva: World Health Organization;2011. cited 2015 Mar 1. Available from: http://www.who.int/iris/handle/10665/44586#sthash.Cdd-BEYMy.dpuf.

34. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010; 363:1005–1015.

35. World Health Organization. Xpert MTB/RIF implementation manual: technical and perational 'how-to': practical considerations [Internet]. Geneva: World Health Organization;2014. cited 2015 Mar 1. Available from: http://apps.who.int/iris/bitstream/10665/112469/1/9789241506700_eng.pdf.

36. Chan HS, Sun AJ, Hoheisel GB. Bronchoscopic aspiration and bronchoalveolar lavage in the diagnosis of sputum smearnegative pulmonary tuberculosis. Lung. 1990; 168:215–220.

37. Seong GM, Lee J, Lee JH, Kim JH, Kim M. Usefulness of sputum induction with hypertonic saline in a real clinical practice for bacteriological yields of active pulmonary tuberculosis. Tuberc Respir Dis. 2014; 76:163–168.

38. Colebunders R, Bastian I. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis. 2000; 4:97–107.

39. Siddiqi K, Lambert ML, Walley J. Clinical diagnosis of smearnegative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis. 2003; 3:288–296.

40. Lee JJ, Chong PY, Lin CB, Hsu AH, Lee CC. High resolution chest CT in patients with pulmonary tuberculosis: characteristic findings before and after antituberculous therapy. Eur J Radiol. 2008; 67:100–104.

41. Chawla R, Pant K, Jaggi OP, Chandrashekhar S, Thukral SS. Fibreoptic bronchoscopy in smear-negative pulmonary tuberculosis. Eur Respir J. 1988; 1:804–806.

42. Lee HS, Park KU, Park JO, Chang HE, Song J, Choe G. Rapid, sensitive, and specific detection of Mycobacterium tuberculosis complex by real-time PCR on paraffin-embedded human tissues. J Mol Diagn. 2011; 13:390–394.

43. Park JS, Kang YA, Kwon SY, Yoon HI, Chung JH, Lee CT, et al. Nested PCR in lung tissue for diagnosis of pulmonary tuberculosis. Eur Respir J. 2010; 35:851–857.

44. International standards for tuberculosis care. Wkly Epidemiol Rec. 2006; 81:43–47.

45. Achkar JM, Sherpa T, Cohen HW, Holzman RS. Differences in clinical presentation among persons with pulmonary tuberculosis: a comparison of documented and undocumented foreign-born versus US-born persons. Clin Infect Dis. 2008; 47:1277–1283.

46. Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis. 2007; 44:69–73.

47. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC. International standards for tuberculosis care. Lancet Infect Dis. 2006; 6:710–725.

48. Tattevin P, Che D, Fraisse P, Gatey C, Guichard C, Antoine D, et al. Factors associated with patient and health care system delay in the diagnosis of tuberculosis in France. Int J Tuberc Lung Dis. 2012; 16:510–515.